Bind Therapeutics files for bankruptcy

Bind Therapeutics Inc. (Nasdaq: BIND) filed for Chapter 11 bankruptcy protection. The stock price plummeted $1.08 to $0.37.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.